Edwards Lifesciences Corp (NYSE:EW)
$ 75.38 0.57 (0.76%) Market Cap: 44.12 Bil Enterprise Value: 40.45 Bil PE Ratio: 10.80 PB Ratio: 4.62 GF Score: 84/100

Q2 2023 Edwards Lifesciences Corp Earnings Call Transcript

Jul 26, 2023 / 09:00PM GMT
Release Date Price: $91.63 (-0.05%)
Operator

Greetings, and welcome to the Edwards Lifesciences Second Quarter 2023 Results Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I will now turn the conference over to our host, Mark Wilterding, Senior Vice President, Investor Relations and Treasurer. Thank you. You may begin.

Mark Wilterding
Edwards Lifesciences Corporation - VP of IR

Thank you very much, Diego. Good afternoon, and thank you all for joining us.

With me on today's call is our Chief Executive Officer, Bernard Zovighian; along with our Chief Financial Officer, Scott Ullem. Also joining us for the Q&A portion of the call are Larry Wood, our Group President of TAVR and Surgical Structural Heart; and Daveen Chopra, our global leader of TMTT; Katie Szyman, our global leader of Critical Care is out of town today, but she'll be with us on future earnings calls.

Just after the close of regular trading, Edwards Lifesciences released second quarter 2023 financial results. During today's call, management will discuss those results

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot